We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-13%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$46B
AUM Growth
-$5.82B
(-11%)
Cap. Flow
+$1.91B
Cap. Flow
% of AUM
4.16%
Top 10 Holdings %
Top 10 Hldgs %
16.37%
Holding
3,033
New
111
Increased
2,420
Reduced
427
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$127M |
| 2 |
Cigna
CI
|
+$54M |
| 3 |
CVS Health
CVS
|
+$38.8M |
| 4 |
Marathon Petroleum
MPC
|
+$28.9M |
| 5 |
Diamondback Energy
FANG
|
+$19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$124M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$100M |
| 3 |
PX
Praxair Inc
PX
|
+$80.2M |
| 4 |
COL
Rockwell Collins
COL
|
+$43.7M |
| 5 |
ANDV
Andeavor
ANDV
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.95% |
| 2 | Financials | 15.85% |
| 3 | Healthcare | 14.41% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Industrials | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GHL
1876
DELISTED
Greenhill & Co., Inc.
GHL
| $1.33M | ﹤0.01% |
54,413
+6,097
| +13% | +$149K |
|
|
CTRL
1877
DELISTED
Control4 Corporation
CTRL
| $1.32M | ﹤0.01% |
75,022
+13,964
| +23% | +$331K |
|
1878
Forrester Research
FORR
$233M
| $1.32M | ﹤0.01% |
29,505
+5,194
| +21% | +$222K |
|
1879
IMAX
IMAX
$2.73B
| $1.32M | ﹤0.01% |
69,941
+22,538
| +48% | +$460K |
|
|
PRO
1880
DELISTED
PROS Holdings
PRO
| $1.31M | ﹤0.01% |
41,806
+15,252
| +57% | +$483K |
|
1881
MYR Group
MYRG
$5.16B
| $1.31M | ﹤0.01% |
46,553
+8,240
| +22% | +$255K |
|
|
CRC
1882
DELISTED
California Resources Corporation
CRC
| $1.31M | ﹤0.01% |
76,688
+15,660
| +26% | +$446K |
|
1883
1st Source
SRCE
$2.15B
| $1.3M | ﹤0.01% |
32,357
+5,520
| +21% | +$257K |
|
1884
DXP Enterprises
DXPE
$3.07B
| $1.3M | ﹤0.01% |
46,823
+8,267
| +21% | +$293K |
|
|
ASNA
1885
DELISTED
Ascena Retail Group, Inc.
ASNA
| $1.3M | ﹤0.01% |
25,949
+4,296
| +20% | +$304K |
|
1886
Stratasys
SSYS
$760M
| $1.3M | ﹤0.01% |
72,198
+22,036
| +44% | +$461K |
|
1887
Pacific Biosciences
PACB
$363M
| $1.29M | ﹤0.01% |
175,028
+64,940
| +59% | +$411K |
|
|
GTT
1888
DELISTED
GTT Communications, Inc.
GTT
| $1.29M | ﹤0.01% |
54,661
+18,598
| +52% | +$626K |
|
1889
JELD-WEN Holding
JELD
$154M
| $1.29M | ﹤0.01% |
90,516
+27,909
| +45% | +$494K |
|
|
CARB
1890
DELISTED
Carbonite Inc
CARB
| $1.28M | ﹤0.01% |
50,863
+23,487
| +86% | +$697K |
|
1891
Team
TISI
$77.8M
| $1.28M | ﹤0.01% |
8,759
+1,446
| +20% | +$264K |
|
|
INOV
1892
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $1.28M | ﹤0.01% |
90,489
+30,660
| +51% | +$349K |
|
|
ESND
1893
DELISTED
Essendant Inc.
ESND
| $1.28M | ﹤0.01% |
102,012
+12,487
| +14% | +$158K |
|
|
GNBC
1894
DELISTED
Green Bancorp, Inc
GNBC
| $1.28M | ﹤0.01% |
74,729
+14,093
| +23% | +$272K |
|
|
MAGN
1895
Magnera Corp
MAGN
$446M
| $1.28M | ﹤0.01% |
10,074
+1,639
| +19% | +$314K |
|
1896
Monarch Casino & Resort
MCRI
$2.19B
| $1.27M | ﹤0.01% |
33,350
+5,966
| +22% | +$242K |
|
1897
American Vanguard Corp
AVD
$73.5M
| $1.27M | ﹤0.01% |
83,529
+15,155
| +22% | +$250K |
|
|
CAMP
1898
DELISTED
CalAmp Corp.
CAMP
| $1.27M | ﹤0.01% |
4,235
+702
| +20% | +$291K |
|
|
BRSL
1899
Brightstar Lottery PLC
BRSL
$2.03B
| $1.26M | ﹤0.01% |
86,429
+1,758
| +2% | +$29.1K |
|
1900
Denali Therapeutics
DNLI
$3.92B
| $1.26M | ﹤0.01% |
60,849
+22,712
| +60% | +$412K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2018 Portfolio in Review
As of Q4 2018, RhumbLine Advisers held 3,033 positions worth $46B, down 11% from $51.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
RhumbLine Advisers deployed $1.91B of net new capital in Q4 2018, opening 111 new positions and adding to 2,420 existing holdings. Its largest new stake was Linde: 805,738 shares worth $126M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $30.2M trimmed.
- RhumbLine Advisers's largest Q4 2018 buy was Linde: 805,738 shares worth $126M.
- RhumbLine Advisers added most to Cigna in Q4 2018, an estimated $54M increase.
- RhumbLine Advisers's biggest Q4 2018 reduction was Apple, cutting an estimated $30.2M.
- RhumbLine Advisers fully exited Aetna Inc in Q4 2018, selling an estimated $124M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $46B portfolio in Q4 2018.
- RhumbLine Advisers opened 111 new positions and closed 53 in Q4 2018.
- RhumbLine Advisers's portfolio value fell 11% quarter-over-quarter to $46B.
Based on RhumbLine Advisers's 13F filing for Q4 2018, filed 31 Jan 2019.